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Abstract The success of Cre-mediated conditional gene target-
ing depends on the specificity of Cre recombinase expression in
Cre-transgenic mouse lines. As a tool to evaluate the specificity
of Cre expression, we developed a reporter transgenic mouse
strain that expresses enhanced green fluorescent protein (EGFP)
upon Cre-mediated recombination. We demonstrate that the
progeny resulting from a cross between this reporter strain and a
transgenic strain expressing Cre in zygotes show ubiquitous
EGFP fluorescence. This reporter strain should be useful to
monitor the Cre expression directed by various promoters in
transgenic mice, including mice in which Cre is expressed
transiently during embryogenesis under a developmentally
regulated promoter.
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1. Introduction
The Cre/loxP site-speci¢c recombination system derived
from bacteriophage P1 provides a convenient tool for tissue-
speci¢c or developmental stage-speci¢c modulation of gene
expression in knockout mice and transgenic mice [1]. For
these studies, various lines of transgenic mice that express
Cre recombinase with di¡erent speci¢city have been gener-
ated. The success of Cre-mediated conditional gene targeting
depends on the speci¢city of the Cre recombinase expression
in Cre-transgenic mouse lines [2]. We reported previously that
a transgenic mouse strain that expresses Escherichia coli
L-galactosidase after Cre-mediated excision of the loxP-
£anked chloramphenicol acetyltransferase (CAT) gene serves
as a useful tool to monitor the speci¢city of Cre expression
[3,4]. Other reporter strains have also been reported, in which
the L-galactosidase^neomycin phosphotransferase fusion gene
(L-geo), inserted in the ROSA26 locus, is expressed only after
Cre-mediated excision of the loxP-£anked sequence [5,6].
Green £uorescent protein (GFP), obtained from the jelly¢sh
Aequorea victoria, yields green £uorescence when excited with
UV light [7^9]. Light-stimulated GFP £uorescence does not
require any co-factors, substrates, or additional gene products
from A. victoria, and can be detected in living cells. Enhanced
GFP (EGFP) is a red-shifted GFP variant with humanized
codon usage, and the green £uorescence of EGFP is 4^35-fold
brighter than that of the wild-type GFP, when excited with
blue light [10]. EGFP is suitable for £uorescence microscopy
and £ow cytometry. Therefore, EGFP has been used as a
novel genetic reporter system in many studies both in vitro
and in vivo.
To create a simple and e⁄cient method for evaluating the
speci¢city of Cre expression, we have developed transgenic
mouse lines carrying a reporter gene construct, CAG-CAT-
EGFP, which directs the expression of EGFP upon the Cre-
mediated excision of the loxP-£anked CAT gene located be-
tween the modi¢ed chicken L-actin promoter with the CMV-
IE enhancer (CAG promoter) [11] and the EGFP gene. Thus,
in these reporter mice, the CAT gene is driven by the CAG
promoter before recombination, while the EGFP gene is driv-
en by the same CAG promoter only after Cre-mediated re-
combination. These reporter mice are expected to produce
green £uorescence in the tissues where Cre-mediated recombi-
nation has occurred, since the CAG promoter is highly active
in a wide range of cell types, even in embryos. In fact, the
‘green mice’ reported by Okabe et al. are transgenic mouse
lines expressing EGFP ubiquitously under the CAG promoter
[12].
Here we crossed one of these reporter lines to a CAG-Cre
transgenic mouse line that expresses Cre under the control of
the CAG promoter. We demonstrate that all tissues examined,
except for red blood cells and hair, of the double transgenic
F1 progeny express EGFP. We also demonstrate that an epi-
dermis-speci¢c expression of EGFP can be obtained in the F1
progeny resulting from a cross between this reporter line and
K5-Cre transgenic mice, in which Cre is driven by a keratin-
ocyte-speci¢c promoter [13]. These results indicate that this
reporter strain should be a useful tool for monitoring the
Cre expression driven by various promoters in transgenic
mouse lines.
2. Materials and methods
2.1. Mice
C57BL/6J mice and BDF1 mice were purchased from Clea Japan
Inc. (Tokyo, Japan). CAG-Cre transgenic mice expressing Cre recom-
binase under the control of the CAG promoter were described pre-
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viously [4]. K5-Cre transgenic mice expressing Cre recombinase under
the control of the keratin 5 (K5) promoter were described previously
[13]. These mice were kept under speci¢c pathogen-free conditions in
our animal facility at Osaka University Medical School. All transgenic
mice used in this study were heterozygous for the transgene.
2.2. Construction of the transgene and generation of transgenic mice
The reporter transgene plasmid was constructed by inserting a Bam-
HI^EcoRI fragment containing EGFP cDNA from pEGFP (Clon-
tech, Palo Alto, CA, USA) and an EcoRI^SacI fragment containing
the rabbit L-globin polyadenylation signal into the BamHI^SacI site
of the pCAG-CAT-Z reporter plasmid in place of the lacZ gene [3].
The resulting pCAG-CAT-EGFP reporter plasmid contained the
CAG promoter, the CAT gene £anked by directly repeated loxP se-
quences, and the EGFP gene (Fig. 1A). The CAG-CAT-EGFP region
was excised from the pCAG-CAT-EGFP plasmid and microinjected
into the pronuclei of one-cell embryos of BDF1UBDF1 mice to pro-
duce transgenic mice. Founder transgenic mice were identi¢ed by
PCR and Southern blot analyses of tail DNA, and bred with
C57BL/6J mice. PCR primers for the transgene detection were as
follows: EGFP forward primer, 5P-AGCAAGGGCGAGGAGC-
TGTT-3P ; EGFP backward primer, 5P-GTAGGTCAGGGTGGT-
CACGA-3P ; Cre forward primer, 5P-AGGTTCGTTCACTCATG-
GA-3P ; Cre backward primer, 5P-TCGACCAGTTTAGTTACCC-3P ;
CAT forward primer, 5P-CAGTCAGTTGCTCAATGTACC-3P ; CAT
backward primer, 5P-ATATCACCAGCTCACCGTCTT-3P.
2.3. Southern blot analysis
Tail tips were lysed in 1% sodium dodecyl sulfate (SDS), 0.2 mg/ml
proteinase K, 10 mM Tris^HCl (pH 7.5), and 1 mM EDTA at 50‡C
for 3 h. DNA was extracted with phenol^chloroform and precipitated
with ethanol. DNA samples (5 Wg) were digested with EcoRI and
subjected to electrophoresis on a 1.2% agarose gel. After denaturation
with 0.5 M NaOH and 1.5 M NaCl, separated DNA fragments were
transferred from the agarose gel onto a nylon membrane (Hybond-N,
Amersham Pharmacia Biotech, Uppsala, Sweden). The BamHI^
EcoRI fragment containing EGFP cDNA from pEGFP was £uores-
cein-labeled by random priming (Random Prime Labeling Module,
Amersham Pharmacia) and used as a probe. The blot was hybridized
with the probe at 62‡C overnight, and processed for autoradiography
using chemiluminescence techniques (CPD-Star Detection Module,
Amersham Pharmacia), according to the manufacturer’s instructions.
2.4. Fluorescence-activated cell sorter (FACS) analysis
Peripheral lymphocytes were prepared by density separation in
Lympholyte-M (Cedar Lane Lab., Ontario, Canada), according to
the manufacturer’s instructions. Thymocytes and splenocytes were
prepared by squeezing whole thymuses or spleens between a pair of
glass slides in phosphate-bu¡ered saline, followed by hemolysis with
ammonium chloride bu¡er. For anti-CD3 staining, cells were incu-
bated with a biotinylated anti-murine CD3 mAb (clone KT3, Beck-
man Coulter, Fullerton, CA, USA), followed by avidin^PE conjugate.
For anti-CD4 staining, cells were incubated with an R-PE-conjugated
anti-murine CD4 mAb (clone L3T4, Pharmingen, San Diego, CA,
USA). Cell suspensions were ¢ltered through 70-Wm nylon mesh,
and subjected to analysis on a FACScan cytometer (Becton Dickin-
son, San Jose, CA, USA). EGFP was excited at 488 nm and detected
using a 510^520-nm band-pass ¢lter.
2.5. Observation of EGFP
Various organs excised from transgenic mice were embedded in
OCT compound (Tissue-TEK, Miles, Elkhart, IN, USA) and frozen
in liquid nitrogen. Sections (10 Wm thick) were cut with a cryostat,
and placed on 3-amino-propyltriethoxysilane-coated slides. Specimens
were examined without ¢xation by £uorescence microscopy (Olympus,
Tokyo, Japan) with a 460^490-nm band-pass excitation ¢lter and a
510-nm long-pass emission ¢lter.
3. Results
3.1. Establishment of CAG-CAT-EGFP transgenic mice
Eleven founder transgenic mice carrying the CAG-CAT-
EGFP transgene (Fig. 1A) were generated, nine of which
transmitted the transgene to the next generation. Four of
these nine transgenic mouse lines (lines 16, 20, 39, and 42)
produced o¡spring expressing EGFP £uorescence detected by
£uorescent microscopy when mated with CAG-Cre transgenic
mice (Fig. 3A). This EGFP £uorescence could also be recog-
nized with the naked eye under UV light. Three of the lines
(20, 39, and 42) were propagated and used in the following
study.
3.2. Cre-mediated recombination in CAG-CAT-EGFP
transgenic mice
CAG-CAT-EGFP transgenic lines were mated with hetero-
zygous CAG-Cre transgenic mice and the F1 progeny were
examined for EGFP expression by £uorescence microscopy
and for genotype by PCR using primer sets speci¢c for the
EGFP and Cre genes. Eleven F1 progeny containing both the
Fig. 1. Structure of the transgene and Cre-mediated recombination.
A: Structure of the CAG-CAT-EGFP transgene. The transgene con-
tains the CAG promoter, the loxP-£anked CAT gene with the SV40
polyadenylation signal, and the EGFP cDNA with the rabbit L-glo-
bin polyadenylation signal. B: Cre-mediated recombination in the
transgene. Before recombination, multiple copies of the transgenes
connected in a head-to-tail manner are present in a chromosome,
and the CAG promoter drives the CAT gene, but not the EGFP
gene (upper). Cre-mediated recombination results in the removal of
all of the loxP-£anked DNA sequences and leaves a single copy of
the transgene in which the EGFP gene is driven by the CAG pro-
moter (lower). E, EcoRI site. C: Southern blot analysis of EcoRI-di-
gested tail DNA of CAG-CAT-EGFP transgenic mice of lines 20,
39, and 42 before and after Cre-mediated recombination. The 2.3-
kb band corresponds to the EcoRI fragment of the unrecombined
transgene. The 1.1-kb band corresponds to the EcoRI fragment of
the recombined transgene. The EGFP cDNA fragment was used as
a probe.
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EGFP and CAG-Cre transgenes were obtained, all of which
were £uorescence-positive. Four F1 progeny from CAG-CAT-
EGFP transgenic malesUCAG-Cre transgenic females were
£uorescence-positive and had the EGFP transgene, but not
the Cre transgene. We have previously reported that the ma-
ture oocytes of heterozygous CAG-Cre transgenic females
contain Cre activity su⁄cient to mediate the deletion of pa-
ternally contributed loxP-£anked DNA sequences upon fertil-
ization irrespective of the transmission of the Cre gene [4].
Our present results suggest that the loxP-£anked CAT gene
was readily removed by the maternally derived Cre activity
retained in transgene-negative oocytes of CAG-Cre transgenic
females.
Southern blot analysis of EcoRI-digested tail DNA con-
¢rmed that the expected recombination had occurred in the
£uorescence-positive F1 progeny from CAG-CAT-EGFP
transgenic mice (lines 20, 39, and 42)UCAG-Cre transgenic
mice. As shown in Fig. 1C, the tail DNA of parental CAG-
CAT-EGFP transgenic mice produced a 2.3-kb band corre-
sponding to the EcoRI fragment from the head-to-tail con-
nected transgenes. According to the densitometric analysis,
the transgene copy number was 22, 21, and 13 in CAG-
CAT-EGFP transgenic mice of lines 20, 39, and 42, respec-
tively. Tail DNA of the £uorescence-positive F1 progeny pro-
duced a 1.1-kb band corresponding to the EcoRI fragment
from a single copy of the recombined transgene, which had
lost the whole loxP-£anked DNA sequence by Cre-mediated
recombination (Fig. 1B).
To examine whether the CAT gene was completely excised
by Cre-mediated recombination in the £uorescence-positive
F1 progeny from CAG-CAT-EGFP transgenic miceUCAG-
Cre transgenic mice, we extracted DNA from the whole em-
bryos at 9.5 days post coitum, and performed PCR analysis
for both the CAT gene and the EGFP gene. We detected the
PCR product from the EGFP gene, but not from the CAT
gene in the £uorescence-positive embryo (not shown). This
result indicated that the loxP-£anked CAT gene was com-
pletely excised by Cre-mediated recombination in the £uores-
cence-positive F1 progeny from CAG-CAT-EGFP transgenic
miceUCAG-Cre transgenic mice, regardless of the multiple
transgene copies in CAG-CAT-EGFP transgenic mice.
3.3. FACS analysis of the lymphocytes of mice with the
recombined allele of the CAG-CAT-EGFP reporter
transgene
We analyzed the expression of EGFP £uorescence in the
peripheral lymphocytes of the F1 mice from CAG-CAT-
EGFP transgenic mice (lines 20, 39, and 42)UCAG-Cre trans-
genic mice, by FACS. The peripheral lymphocytes of the F1
mice of line 39 with the recombined allele of the CAG-CAT-
EGFP transgene showed a single bright peak of £uorescence.
The peripheral lymphocytes of lines 20 and 42 with the re-
combined allele also showed a single peak, although at lower
levels (Fig. 2A). Thymocytes and splenocytes of the F1 mice
of line 39 also showed a single bright peak (Fig. 2B). The
peripheral lymphocytes of the F1 mice with the unrecombined
allele of the transgene did not express £uorescence, and their
background £uorescence levels did not di¡er from those of
non-transgenic littermates (not shown).
3.4. Histological analysis of mice with the recombined allele of
the CAG-CAT-EGFP reporter transgene
To examine the expression of EGFP £uorescence in various
organs of the F1 mice from CAG-CAT-EGFP transgenic mice
UCAG-Cre transgenic mice, we performed histological
analysis by £uorescence microscopy. We examined the brain,
spinal cord, eye, lung, heart, thymus, liver, kidney, spleen,
pancreas, stomach, ileum, colon, and skeletal muscle of the
F1 mice from line 39, which had the recombined allele of the
CAG-CAT-EGFP transgene. All of these tissues expressed
EGFP (Fig. 3). However, red blood cells and hair were neg-
ative for EGFP £uorescence (not shown). Skeletal muscle,
heart, liver, the epithelium of the gut and pancreatic exocrine
tissue expressed strong EGFP £uorescence. Other tissues, in-
cluding brain, kidney and pancreatic islets, expressed consid-
erably lower levels of £uorescence. As shown in Fig. 3K,
pancreatic islets showed very weak £uorescence compared
with the exocrine part of the pancreas. However, £uorescence
of isolated islets was clearly detectable by £uorescence micros-
copy (Fig. 3L). On the other hand, we could not detect EGFP
£uorescence in any tissue of the F1 mice with the un-
recombined allele of the CAG-CAT-EGFP transgene (not
shown).
Fig. 2. FACS analysis of the white blood cells of mice with the re-
combined allele of the CAG-CAT-EGFP transgene. A: Peripheral
lymphocytes of the F1 progeny from the reporter mice (lines 20, 39,
and 42)Uthe CAG-Cre transgenic mice expressed EGFP, while
those of the parental reporter mice of line 39 with the unrecom-
bined transgene (CAG-CAT-EGFP) showed background £uores-
cence. B: Thymocytes and splenocytes of the F1 progeny from the
reporter mice of line 39UCAG-Cre transgenic mice expressed
EGFP uniformly. Gray lines indicate the £uorescence intensity of
the cells from the reporter mice of line 39 with the unrecombined
transgene.
FEBS 23477 23-3-00 Cyaan Magenta Geel Zwart
S. Kawamoto et al./FEBS Letters 470 (2000) 263^268 265
FEBS 23477 23-3-00 Cyaan Magenta Geel Zwart
S. Kawamoto et al./FEBS Letters 470 (2000) 263^268266
3.5. Keratinocyte-speci¢c expression of EGFP in the F1
progeny from CAG-CAT-EGFP reporter miceUK5-Cre
transgenic mice
To examine tissue-speci¢c recombination in this reporter
strain, we mated CAG-CAT-EGFP reporter mice of line 39
with K5-Cre transgenic mice, which express Cre exclusively in
keratinocytes. As shown in Fig. 4D, the body surface of the
double transgenic F1 mouse from CAG-CAT-EGFP reporter
miceUK5-Cre transgenic mice expressed £uorescence. A
transverse section of its tail showed that the expression of
EGFP was limited to the skin (Fig. 4E), while the tail of
the F1 mouse from CAG-CAT-EGFP reporter miceUCAG-
Cre transgenic mice expressed EGFP not only in the skin, but
also in other inner tissues (Fig. 4F). Detailed examination of
the back skin of the F1 progeny from CAG-CAT-EGFP re-
porter miceUK5-Cre transgenic mice revealed that EGFP
£uorescence was expressed exclusively in the epidermis and
hair follicles as expected from the speci¢city of the K5 pro-
moter (Fig. 4H). EGFP £uorescence was also observed in the
epithelium of the tongue, the esophagus, and forestomach, in
which the K5 promoter has been reported to be active (not
shown).
4. Discussion
We have generated CAG-CAT-EGFP reporter transgenic
mouse lines that express EGFP £uorescence after Cre-medi-
ated excision of the loxP-£anked CAT gene sequence within
the transgene. The features of this reporter strain are as fol-
lows: (1) EGFP is used as the reporter; (2) the ubiquitously
strong CAG promoter is used to drive the reporter gene; (3)
the reporter gene construct includes the loxP-£anked CAT
gene sequence between the CAG promoter and the EGFP
gene; (4) this reporter gene is switched on by Cre-mediated
recombination. In the present study, we demonstrated that the
F1 progeny obtained by mating one of these reporter lines
(line 39) with CAG-Cre transgenic mice, which produce Cre
in zygotes, expressed EGFP £uorescence in all tissues exam-
ined. We also demonstrated that tissue-speci¢c expression of
EGFP was induced in the double transgenic F1 progeny ob-
tained by mating this reporter line with transgenic mice ex-
pressing Cre in a tissue-speci¢c manner. Although strong £uo-
rescence was detected in most of the tissues examined in mice
with the recombined allele of the CAG-CAT-EGFP trans-
gene, some tissues such as kidney and spinal cord showed
Fig. 4. Epidermis-speci¢c expression of EGFP in the F1 progeny from CAG-CAT-EGFP reporter mice of line 39UK5-Cre transgenic mice.
A: Appearance of the tail tips of a double transgenic newborn mouse (upper) and a non-transgenic littermate (lower). B: Transverse section of
the tail of a double transgenic F1 mouse from the reporter mice of line 39UK5-Cre transgenic mice. C: Transverse section of the tail of an F1
mouse with the recombined transgene from the reporter mice of line 39UCAG-Cre transgenic mice. G: Detailed examination of the back skin
of a double transgenic F1 mouse from the reporter mice of line 39UK5-Cre transgenic mice. D, E, F, and H: The same samples as in A, B,
C, and G, respectively, were examined for EGFP expression by £uorescence microscopy. In H, the arrow indicates a hair follicle.
Fig. 3. Appearance and histological analysis of the F1 progeny from CAG-CAT-EGFP reporter mice of line 39Uthe CAG-Cre transgenic
mice. A: Expression of EGFP on the body surface of a neonatal F1 mouse was examined by £uorescence microscopy. B^M: Histological anal-
ysis. Organs of the F1 progeny with the recombined transgene were frozen in liquid nitrogen, and 10 mm thick sections were cut with a cryo-
stat. Pancreatic islets were isolated by collagenase digestion followed by Ficoll density gradient puri¢cation. Un¢xed specimens were examined
by £uorescence microscopy. B, brain; C, eye; D, skeletal muscle; E, heart; F, lung; G, spleen; H, liver; I, ileum; J, colon; K, pancreas;
L, isolated pancreatic islets; M, kidney.
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only weak £uorescence especially after paraformaldehyde ¢x-
ation. Therefore, our reporter mice may not be suitable for
the detection of Cre expression speci¢c to these tissues.
EGFP would be a good reporter protein to monitor the
expression of Cre, because it is less cytotoxic and simpler to
detect than L-galactosidase. Since the £uorescence can be de-
tected in living cells, this reporter strain would be useful in
various applications, such as collecting Cre-expressing cells by
FACS. However, it is essential to use a strong promoter to
drive the EGFP gene in these studies. Previously we found
that it was di⁄cult to detect the £uorescence in embryonic
stem cells when the EGFP gene was driven by the phospho-
glycerate kinase-1 promoter. In this study, we utilized the
CAG promoter to drive the reporter gene and could easily
detect the £uorescence of EGFP in various tissues by £uores-
cence microscopy and FACS. This observation is consistent
with the description of the previously reported ‘green mice’,
which express EGFP under the control of the CAG promoter
[12]. It is known that the ROSA26 locus identi¢ed by the gene
trapping method has a ubiquitously active promoter. How-
ever, this promoter activity does not seem to be as strong as
the CAG promoter and would not be appropriate to drive the
EGFP-based reporter gene. On the other hand, Cre recombi-
nase can e⁄ciently excise the loxP-£anked DNA sequences in
mammalian chromosomes and even a residual amount of Cre
recombinase is thought to be able to switch on this reporter
system, leading to EGFP expression. Thus, our reporter sys-
tem is expected to be used to detect even weakly expressed
Cre, because the EGFP £uorescence driven by the CAG pro-
moter results in such a strong signal.
The CAG-CAT-EGFP reporter mice have multiple copies
of the transgene. Although our results indicated that the loxP-
£anked DNA sequences was completely excised by Cre-medi-
ated recombination in the £uorescence-positive F1 progeny
from CAG-CAT-EGFP transgenic miceUCAG-Cre transgen-
ic mice, it is possible that weak Cre expression may result in
partial deletion of the loxP-£anked DNA sequences and that
each cell may express CAT and/or EGFP, depending on the
status of the deletion. Thus, it would be necessary to examine
the EGFP expression in the F1 progeny from our reporter
miceUtransgenic mice expressing Cre recombinase at low lev-
els.
The present study indicates that the novel reporter strain of
CAG-CAT-EGFP transgenic mice could serve as a simple and
e⁄cient tool, both to monitor the tissue speci¢city of Cre
expression in transgenic mice in which the Cre gene is driven
by various promoters, and to analyze the fate of cells deriving
from progenitors that transiently express Cre during embryo-
genesis under some developmentally regulated promoter.
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